Discover. Accelerate. Advance.
Join Our Experts at GTA 2025 for Scientific Insights and Networking.
Our subject matter expert Kevin Cross will also be co-chairing and sharing the recent developments in the Carcinogenic Potency Categorization Approach (CPCA) in a symposium session. See below for further details.
We look forward to meeting you.
Friday, May 9
Symposium VI – Nitrosamines – Current Updates, Regulatory Experience
Title: (Q)SAR of nitrosamines and the CPCA. Where do we go from here?
Presented by: Kevin Cross, PhD, Director of In Silico Science, Instem
Where: Clayton Hall, University of Delaware, Newark, USA
When: 9th May 2025, 3 PM-3:20 PM
Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision-making leading to safer, more effective products.
Instem’s Genetic Toxicology Solutions
Cyto Study Manager™
GLP-compliant platform streamlining genetox studies across assays (Ames, Comet, Micronucleus, etc.). Enables direct instrument data import, automated reporting, SEND generation, and full workflow integration.
Leadscope Model Applier (LMA)™: In Silico Tox Software
A powerful computational toxicology tool designed for rapid screening and regulatory-compliant risk assessment. Evaluate thousands of compounds, leveraging pre-built and transparent models accepted by global regulatory agencies.
Predict™: In Silico Tox Service
Delivers regulatory-aligned assessments for applications including ICH M7, N-nitrosamine acceptable limits, extractables and leachables, and classification and labeling. The service includes SD file generation for eCTD submissions and expert-reviewed results to support high-confidence regulatory submissions.
Comet Assay IV™
Semi-automated, live-video comet scoring system enabling slide analysis in two minutes. Features include Oracle database support, hedgehog detection, and integration with Cyto Study Manager™.
Sorcerer Colony Counter™
Integrated Ames test solution with automated plate counting, concurrent control sharing, and Microsoft Word reporting. Compatible with Cyto Study Manager™ and supports any experimental design.